Literature DB >> 6339622

Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane.

B Perussia, O Acuto, C Terhorst, J Faust, R Lazarus, V Fanning, G Trinchieri.   

Abstract

In this paper, we characterize the antigen recognized by the monoclonal antibody B73.1 and the modification occurring at the membrane of the positive cells after interaction with the antibody. The B73.1-defined antigen is a protein of 50,000 to 72,000 daltons that is sensitive to pronase but not to trypsin treatment. B73.1 antibody, and its F(ab')2 fragment, directly block, at high concentrations, the binding of IgG antibody-sensitized erythrocytes to the Fc receptors (FcR) of a subpopulation of lymphocytes and neutrophils. B73.1 antibody dissociates rapidly from the positive cells, but concomitant modulation of both B73.1 antigen and FcR is induced when cells are incubated in the continuous presence of antibody or when B73.1 antibody is cross-linked at the cell membrane with an anti-mouse immunoglobulin antiserum. Reaction of lymphocytes with immune complexes also induces modulation of both FcR and B73.1 antigen, without affecting the expression of other antigens on the positive cells. The possibility that the antigen is internalized and digested by the cell after reaction with the antibody is discussed. B73.1 antibody inhibits antibody-dependent cytotoxicity mediated by lymphocytes (K cells) and neutrophils, whereas it does not affect spontaneous cytotoxicity of NK cells. These results suggest the B73.1-defined antigen might be the FcR or a structure closely related to it on K/NK cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339622

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  Concurrent and independent binding of Fcgamma receptors IIa and IIIb to surface-bound IgG.

Authors:  T E Williams; S Nagarajan; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  Adhesion and activation molecules expressed by human natural killer cells.

Authors:  A Santoni; A Gismondi; R Paolini; A Procopio; S Morrone; F Mainiero; G Santoni; M Piccoli; L Frati
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

3.  The specificity of the human neutrophil IgA receptor (Fc alpha R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2.

Authors:  W W Stewart; M A Kerr
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

4.  A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms.

Authors:  B J Scallon; E Scigliano; V H Freedman; M C Miedel; Y C Pan; J C Unkeless; J P Kochan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 5.  Dendritic cell interactions with NK cells from different tissues.

Authors:  Guido Ferlazzo; Christian Münz
Journal:  J Clin Immunol       Date:  2009-03-12       Impact factor: 8.317

6.  Functional surface structures on human natural killer cells.

Authors:  R E Schmidt; T Hercend; S F Schlossman; J Ritz
Journal:  Klin Wochenschr       Date:  1985-12-02

7.  Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells.

Authors:  P Anderson; M Caligiuri; C O'Brien; T Manley; J Ritz; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

8.  Purification and characterization of cytolytic and noncytolytic human natural killer cell subsets.

Authors:  L T Lebow; B Bonavida
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

9.  Human natural killer (NK) cells produce a late-acting B-cell differentiation activity.

Authors:  H Kimata; E H Sherr; A Saxon
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

10.  Involvement of cell surface macromolecules sensitive to alkylating ketones in lysis by human peripheral blood NK cells.

Authors:  M M Dawson; U Shipton; M Moore
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.